Binnopharm Group to open representative offices in six countries as part of its international expansion
Binnopharm Group has registered an official representative office in Kazakhstan and expects to secure representation in five more CIS countries next month – Belarus, Azerbaijan, Moldova, Armenia, and Uzbekistan. This move will help double its export revenue in 2024 and will serve as the first step towards infrastructure conducive to global expansion.
Binnopharm Group closes order book for its debut issue of 001P-01 series bonds worth RUB 3 bn
Binnopharm Group and Sartorius partner to manufacture biotechnological medicines and vaccines against COVID-19
Expert RA assigns an expected ruA credit rating to Binnopharm Group’s planned bond issue
Binnopharm Group, a holding company that combines Sistema’s pharmaceutical assets, announces that the Expert RA rating agency has assigned an expected ruA credit rating (EXP) to the company’s planned RUB 3 bn 001P-01 series bond issue. The securities will be placed under a registered exchange bond programme worth up to RUB 50 bn with a maximum maturity of 15 years.